Ultrastructural changes in dysferlinopathy support defective membrane repair mechanism

Journal of Clinical Pathology

Volumn 58, Issue 2, 2005, Pages 190-195

  Cenacchi, G ^b   Fanin, M ^c   De Giorgi, L B ^b   Angelini, C ^a,c  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DYSFERLIN;

ADOLESCENT; ADULT; ARTICLE; BASEMENT MEMBRANE; CELL VACUOLE; CLINICAL ARTICLE; DYSFERLINOPATHY; FEMALE; GOLGI COMPLEX; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIMB GIRDLE MUSCULAR DYSTROPHY; MALE; MIYOSHI MYOPATHY; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE REGENERATION; MYOPATHY; PRIORITY JOURNAL; SARCOLEMMA; SARCOPLASM; SKELETAL MUSCLE;

ADOLESCENT; ADULT; BASEMENT MEMBRANE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; MICROSCOPY, ELECTRON; MUSCLE FIBERS; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; MYOSITIS; SARCOLEMMA; SARCOPLASMIC RETICULUM;

EID: 13244284886     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2004.018978     Document Type: Article

References (18)

1. Zatz M, de Paula F, Starling A, et al. The 10 autosomal recessive limb-girdle muscular dystrophies. Neuromuscul Disord 2003;13:532-44.
2. Laval SH, Bushby KM. Limb-girdle muscular dystrophies-from genetics to molecular pathology. Neuropathol Appl Neurobiol 2004;30:91-105.
3. Camponaro S, Romualdi C, Fanin M, et al. Gene expression profiling in dysferlinopathies using a dedicated muscle microarray. Hum Mol Genet 2002;11:3283-98.
4. Fanin M, Angelini C. Muscle pathology in dysferlin deficiency. Neuropathol Appl Neurobiol 2002;28:461-70.
5. Bansal D, Miyake K, Vogel SS, et al. Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature 2003;423:168-72.
6. Doherty KR, McNally EM. Repairing the tears: dysferlin in muscle membrane repair. Trends Mol Med 2003;9:327-30.
7. Gallardo E, Rojas-Garcia R, de Luna N, et al. Inflammation in dysferlin myopathy: immunohistochemical characterization of 13 patients. Neurology 2001;57:2136-8.
8. Confalonieri P, Oliva L, Andreetta F, et al. Muscle inflammation and MHC class I up-regulation in muscular dystrophy with lack of dysferlin: an immunopathological study. J Neuroimmunol 2003;142:130-6.
9. Kostek CA, Dominov JA, Miller JB. Up-regulation of MHC class I expression accompanies but is not required for spontaneous myopathy in dysferlin-deficient SJL/J mice. Am J Pathol 2002;160:833-9.
10. Selcen D, Stilling G, Engel AG. The earliest pathologic alterations in dysferlinopathy. Neurology 2001;56:1472-81.
11. Hayashi YK. Membrane-repair machinery and muscular dystrophy. Lancet 2003;362:843-4.
12. Piccolo F, Moore SA, Ford GC, et al. Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb-girdle muscular dystrophies. Ann Neurol 2000;48:902-12.
13. McNeil PL. Repairing a torn cell surface: make way, lysosomes to the rescue. J Cell Sci 2002;115:873-9.
14. Lennon NJ, Kho A, Bacskai BJ, et al. Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing. J Biol Chem 2003;278:50466-73.
15. Minetti C, Bado M, Broda P, et al. Impairment of caveolae formation and T-system disorganization in human muscular dystrophy with caveolin-3 deficiency. Am J Pathol 2002;160:265-70.
16. Matsuda C, Hayashi YK, Ogawa M, et al. The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle. Hum Mol Genet 2001;10:1761-6.
17. Capanni C, Sabatelli P, Mattioli E, et al. Dysferlin in a hyperCKaemic patient with caveolin 3 mutation and in C2C12 cells after p38 MAP kinase inhibition. Exp Mol Med 2003;35:538-44.
18. Ho M, Post CM, Donahue LR, et al. Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin-deficiency. Hum Mol Genet 2004;13:1999-2010.